Post Profile

Israel's Teva Pharma appoints H Lundbeck's Kare Schultz as CEO

(Reuters) - Teva Pharmaceutical Industries Ltd named H Lundbeck A/S Chief Executive Kare Schultz as its new CEO and president, the Israel-based drugmaker said on Monday.
read more


Related Posts

U.S. FDA raises concerns over Teva's plant in China

Health : Reuters: Health

(Reuters) - The U.S. Food and Drug Administration (FDA) has raised concerns over manufacturing controls at a Teva Pharmaceutical Industries plant in China, Israel's biggest company said in a regulatory filing on Thursday.

As Teva wins U.S. approval for GSK Advair copy, main fight yet to come

Health : Reuters: Health

LONDON (Reuters) - Israel's Teva Pharmaceutical Industries has won U.S. approval to market a copy of GlaxoSmithKline's best-selling Advair inhaler, although the real battle is still to come.

Ben-Gurion U. researchers and Teva Pharmaceutical Industries Ltd. develop psoriasis drug

Academics / General Science : Science Codex

BEER-SHEVA, Israel, March 20, 2013 -- Ben-Gurion University of the Negev (BGU) researchers, in collaboration with Teva Pharmaceutical Industries Ltd., have developed a promising drug candidate to treat psoriasis. The finding was rep...

Taro Pharmaceutical Industries Ltd. (TARO), Teva Pharmaceutical Industries Ltd (ADR) (TEVA): Conquer the Generic Drug Market With Taro

Business & Finance / Investing : Insider Monkey

Taro Pharmaceutical Industries Ltd. (NYSE:TARO) hardly gets the attention it deserves. The Israel-based generic-pharmaceutical manufacturer supplies in Israel, the U.S., Canada, the U.K., Ireland and in a few other countries. The co...

Teva to buy U.S. drug developer Auspex Pharma for $3.5 billion

Business & Finance : Business Insider: Clusterstock

By Tova Cohen TEL AVIV (Reuters) - Israel's Teva Pharmaceutical Industries said it would buy U.S. biopharmaceutical firm Auspex Pharmaceuticals Inc for an equity value of $3.5 billion to boost its portfolio of treatments for the cen...


Copyright © 2016 Regator, LLC